All
Immunotherapy Plus Chemo Boosts Event-Free Survival in Resectable Lung Cancer
January 18th 2023Patients with operable non-small cell lung cancer who were treated with an anti-PD-1 monoclonal antibody plus a doublet chemotherapy regiment did not experience cancer recurrence or new symptom onset during follow-up in a recent study.
Beta-Blockers May Improve Post-Surgical Survival in Women With Ovarian Cancer, Heart Conditions
January 18th 2023Women who were taking beta-blockers, a medicine to treat heart conditions like high blood pressure, among others, near the time of surgery for epithelial ovarian cancer may confer a survival benefit years after undergoing a procedure.